ATC Group: A10AC Insulins and analogues for injection, intermediate-acting

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A10AC in the ATC hierarchy

Group A10AC contents

Active ingredients in A10AC

Active Ingredient
Description

The blood glucose lowering effect of insulin is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver.

The primary activity of insulin lispro is the regulation of glucose metabolism.

Related product monographs

Title
Information Source
Document Type
 
Medicines & Healthcare Products Regulatory Agency (GB)
MPI, EU: SmPC
Medicines & Healthcare Products Regulatory Agency (GB)
MPI, EU: SmPC
European Medicines Agency (EU)
MPI, EU: SmPC